
Dyadic International DYAI
€ 0.35
0.0%
Dyadic International ROCE | DYAI
ROCE Jährlich Dyadic International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -583.64 | -238.87 | -140.0 | -91.68 | -80.08 | -35.02 | -25.81 | -17.84 | -14.76 | -10.07 | -4.94 | -88.53 | 4.38 | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 4.38 | -583.64 | -102.07 |
ROCE Vierteljährlich Dyadic International
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 649.24 | 502.42 | 35.77 | 29.83 | 39.2 | -334.29 | -117.48 | -139.96 | -159.51 | -114.02 | -66.95 | -81.72 | -83.71 | -74.96 | -55.98 | -71.16 | -73.08 | -12975.11 | -12958.37 | -12967.42 | -12962.08 | -12953.76 | -27.27 | -32.69 | -31.89 | -28.86 | -20.48 | -24.68 | -23.54 | -20.53 | -13.73 | -4.2 | -4.28 | -5.25 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 649.24 | -12975.11 | -1916.78 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Infinity Pharmaceuticals
INFI
|
235.39 | - | -46.98 % | $ 3.57 M | ||
|
OncoSec Medical Incorporated
ONCS
|
-604.93 | - | 31.87 % | $ 1.61 M | ||
|
Ayala Pharmaceuticals
AYLA
|
3412.47 | - | - | $ 7.46 M | ||
|
Evelo Biosciences
EVLO
|
2172.8 | - | -14.46 % | $ 27.9 M | ||
|
BioDelivery Sciences International
BDSI
|
19.77 | - | -4.8 % | $ 255 M | ||
|
Morphic Holding
MORF
|
-25.64 | - | - | $ 2.42 B | ||
|
Novan
NOVN
|
-743.32 | - | -24.84 % | $ 2.64 M | ||
|
Genocea Biosciences
GNCA
|
-192.4 | - | -15.0 % | $ 3.04 M | ||
|
Eiger BioPharmaceuticals
EIGR
|
496.51 | - | -9.21 % | $ 2.55 M | ||
|
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | ||
|
BELLUS Health
BLU
|
-19.87 | - | - | $ 2.47 B | ||
|
bluebird bio
BLUE
|
857.68 | - | - | $ 546 M | ||
|
Intra-Cellular Therapies
ITCI
|
-10.16 | - | - | $ 13.6 B | ||
|
IGM Biosciences
IGMS
|
-432.99 | - | - | $ 76.9 M | ||
|
Marinus Pharmaceuticals
MRNS
|
-784.28 | - | - | $ 29.6 M | ||
|
Merrimack Pharmaceuticals
MACK
|
-10.87 | - | - | $ 216 M | ||
|
CASI Pharmaceuticals
CASI
|
-76.35 | - | - | $ 35.4 M | ||
|
ContraFect Corporation
CFRX
|
545.12 | - | -5.16 % | $ 5.39 M | ||
|
Sigilon Therapeutics
SGTX
|
-111.56 | - | - | $ 728 M | ||
|
Rubius Therapeutics
RUBY
|
-1179.34 | - | -33.55 % | $ 7.81 M | ||
|
Aptinyx
APTX
|
-163.42 | - | -39.0 % | $ 4.57 M | ||
|
TRACON Pharmaceuticals
TCON
|
1146.23 | - | -1.38 % | $ 46.8 M | ||
|
Mirati Therapeutics
MRTX
|
-76.22 | - | - | $ 3.3 B | ||
|
Revance Therapeutics
RVNC
|
208.95 | - | - | $ 309 M | ||
|
Allogene Therapeutics
ALLO
|
-71.55 | $ 0.93 | -11.99 % | $ 205 M | ||
|
InVivo Therapeutics Holdings Corp.
NVIV
|
-67.64 | - | -37.48 % | $ 476 K | ||
|
Epizyme
EPZM
|
1150.39 | - | - | $ 249 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
-1339.01 | - | -9.72 % | $ 5.89 M | ||
|
ORIC Pharmaceuticals
ORIC
|
-37.21 | $ 8.9 | -3.63 % | $ 781 M | ||
|
Forward Pharma A/S
FWP
|
-5.47 | - | -0.75 % | $ 18.7 M | ||
|
Orchard Therapeutics plc
ORTX
|
-129.33 | - | 1.02 % | $ 90.8 M | ||
|
La Jolla Pharmaceutical Company
LJPC
|
-32.71 | - | - | $ 154 M | ||
|
Oyster Point Pharma
OYST
|
-97.1 | - | - | $ 300 M | ||
|
Nabriva Therapeutics plc
NBRV
|
-1333.89 | - | - | $ 4.55 M | ||
|
Intercept Pharmaceuticals
ICPT
|
-20.32 | - | - | $ 643 M | ||
|
NGM Biopharmaceuticals
NGM
|
-101.9 | - | - | $ 127 M | ||
|
Regulus Therapeutics
RGLS
|
-65.49 | - | - | $ 155 M | ||
|
9 Meters Biopharma
NMTR
|
-1750.31 | - | -42.97 % | $ 1.05 M | ||
|
Chinook Therapeutics
KDNY
|
-41.88 | - | - | $ 2.6 B | ||
|
Lumos Pharma
LUMO
|
-134.09 | - | - | $ 35.3 M | ||
|
Syros Pharmaceuticals
SYRS
|
-774.14 | - | -8.44 % | $ 3.4 M | ||
|
NanoViricides
NNVC
|
-95.66 | $ 1.44 | 8.27 % | $ 29.1 M | ||
|
Gamida Cell Ltd.
GMDA
|
-46.52 | - | -18.25 % | $ 5.04 M | ||
|
GT Biopharma
GTBP
|
-214.65 | $ 3.99 | -7.64 % | $ 22 M | ||
|
Aravive
ARAV
|
-664.7 | - | -13.39 % | $ 1.45 M | ||
|
Bellerophon Therapeutics
BLPH
|
-883.35 | - | -74.18 % | $ 955 K | ||
|
BioLineRx Ltd.
BLRX
|
-35.74 | $ 1.52 | -3.8 % | $ 3.75 B | ||
|
VistaGen Therapeutics
VTGN
|
-203.06 | $ 0.18 | -0.46 % | $ 6.85 M | ||
|
C4 Therapeutics
CCCC
|
-35.34 | $ 3.0 | -4.76 % | $ 249 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-146.69 | $ 1.67 | -0.6 % | $ 2.75 M |